Rationale and design of the real-world Hellenic disease management patterns with everolimus for women with hormone-receptor-positive, human epidermal growth factor ReceptOR-2 negative advanced breast cancer (The MIRROR) study

Authors :: V. Barbounis
Christos Papadimitriou
I. Xanthakis
C. Karanikiotis
G. Kesisis
C. Panopoulos
C. Andreadis
Athanasios Alexopoulos
Source :: The Breast. 32:S69
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
Pathology
Everolimus
business.industry
Advanced breast
Cancer
General Medicine
medicine.disease
Hormone receptor
Internal medicine
medicine
Surgery
Disease management (health)
business
Human Epidermal Growth Factor Receptor 2
medicine.drug

Full Text Access

Tools